Skip to main content
OpenTrials

Clinical trial condition

Urologic Diseases

Explore clinical trials studying Urologic Diseases. Study availability and eligibility vary by location and protocol.

13,827 public trials 2,184 recruiting studies
Refine in advanced search Browse all conditions

Urologic Diseases trial results

Completed

A Prospective, Randomised, Double-blind, Double-dummy, Forced-titration, Multicentre, Parallel Group, One Year Treatment Trial to Compare Telmisartan (MICARDIS) 80 mg Versus Losartan (COZAAR) 100 mg, in Hypertensive Type 2 Diabetic Patients With Overt Nephropathy (AMADEO Study)

NCT00168857

Conditions
Cardiovascular Diseases, Diabetes Complications, Diabetes Mellitus, +10 more
Locations
  • Boehringer Ingelheim Investigational Site Montgomery, Alabama, United States
  • Boehringer Ingelheim Investigational Site Little Rock, Arkansas, United States
  • Boehringer Ingelheim Investigational Site Lancaster, California, United States
  • Boehringer Ingelheim Investigational Site Los Angeles, California, United States
View all 109 locations
View Trial Details
Completed

Vascular Endothelial Growth Factor-B (VEGF-B) Blockade With the Monoclonal Antibody CSL346 in Subjects With Diabetic Kidney Disease

NCT04419467

Conditions
Diabetes Complications, Diabetes Mellitus, Diabetic Kidney Disease (DKD), +8 more
Locations
  • California Kidney Specialists (CKS) - Citrus Office Covina, California, United States
  • Valley Research - Fresno Fresno, California, United States
  • Torrance Clinical Research (TCR) - Lomita Lomita, California, United States
  • Renal Medical Associate/NARI Lynwood, California, United States
View all 37 locations
View Trial Details
Completed

Dose-Finding and Safety Study for Oral Single-Agent to Treat Advanced Malignancies

NCT02030067

Conditions
Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, Male Urogenital Diseases, +14 more
Locations
  • Rexahn Site Birmingham, Alabama, United States
  • Rexahn Site Tucson, Arizona, United States
  • Rexahn Site Duarte, California, United States
  • Rexahn Site Miami, Florida, United States
View Trial Details
Completed

Current Treatment Outcomes in Japanese RCC Patients Treated With Avelumab Plus Axitinib as First-line Therapy: Retrospective Study (J-DART)

NCT05012865

Conditions
Adenocarcinoma, Carcinoma, Carcinoma, Renal Cell, +14 more
Locations
  • Kurume University Hospital Kurume, Fukuoka, Japan
  • Gunma Prefectural Cancer Center Ōta, Gunma, Japan
  • Asahikawa Medical University Hospital Asahikawa, Hokkaido, Japan
  • Iwamizawa Municipal General Hospital Iwamizawa, Hokkaido, Japan
View Trial Details

Related conditions